Neuroscientists are mining nucleic acids, blood, saliva, and brain images in hopes of uncovering biomarkers that could help estimate risk of brain disorders like psychosis and dementia; though the science of bioprediction is young, its prospects are unearthing controversy about how bioprediction should enter hospitals, courtrooms, or state houses. While medicine, law, and policy have established protocols for how presence of disorders should change what we owe each other or who we blame, they have no stock answers for the probabilities that bioprediction offers. The Neuroethics of Biomarkers observes, however, that for many disorders, what we really care about is not their presence per se, but certain risks that they carry. The current reliance of moral and legal structures on a categorical concept of disorder (sick verses well), therefore, obscures difficult questions about what types and magnitudes of probabilities matter. Baum argues that progress in the neuroethics of biomarkers requires the rejection of the binary concept of disorder in favor of a probabilistic one based on biological variation with risk of harm, which Baum names a "Probability Dysfunction." This risk-reorientation clarifies practical ethical issues surrounding the definition of mental disorder in the DSM-5 and the nosology of conditions defined by risk of psychosis and dementia. Baum also challenges the principle that the acceptability of bioprediction should depend primarily on whether it is medically useful by arguing that biomarkers can also be morally useful through enabling moral agency, better assessment of legal responsibility, and fairer distributive justice. The Neuroethics of Biomarkers should be of interest to those within neuroethics, medical ethics, and the philosophy of psychiatry.
Collen , Morris F. , Leonard Rubin , and Lou S. Davis . " Computers in Multiphasic Screening . " In Computers in Biomedical Research , vol . 1 , ed . Ralph W. Stacy and Bruce Waxman , chap . 14. New York : Academic Press , 1965 .
Talwar S, Squire IB, Downie PF, Davies JE, Ng LL. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart. 2000;84:421-4. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda ...
Shepherd, B.S., Burch, A, Ron, B., Richman, N.H., Shimoda, S.K., Stetson, M.H., Lim, C, and Grau, E.G., 1997a, Effects of salinity, dietary levels of protein and 17a- methyltestosterone on growth hormone (GH) and prolactin (tPRL177 and ...
Rising interest in how diseases evolve through the monitoring of biological markers has created the need for enhanced sensing techniques. Immunoassay and matrix-assisted laser desorption/ionization time of flight mass spectrometry...
Bengtson. University of Rhode Island, Department of Biological Sciences, Kingston, RI 02881; Symposium Chairperson and Editor. Biomarkers Brent D. Palmer1 and Kyle W. Selcer2 VITELLOGENIN AS OVERVIEW xiii.
Cardiac Biomarkers in Clinical Practice
This book provides a comprehensive overview of the diagnosis and management of Non-alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatis (NASH).
Opening with an introduction to the field of computational toxicology and its current and potential applications, the volume continues with ’best practices’ in mathematical and computational modeling, followed by chemoinformatics and ...
Biological Indicators of Stress in Fish
In: Comprehensive foodomics. Elsevier, Amsterdam, pp 568–578. https://doi.org/10.1016/B978-0-08-100596-5. 22881-3 Ye D et al (2019) Significant function and research progress of biomarkers in gastric cancer (Review).